Sanofi
SNYNF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $95,261,608 | $99,451,125 | $125,803,450 | $114,742,485 |
| - Cash | $8,906,000 | $15,359,000 | $7,991,000 | $7,441,000 |
| + Debt | $21,755,000 | $22,285,000 | $21,047,000 | $17,906,000 |
| Enterprise Value | $108,110,608 | $106,377,125 | $138,859,450 | $125,207,485 |
| Revenue | $13,170,000 | $10,735,000 | $10,606,000 | $11,420,000 |
| % Growth | 22.7% | 1.2% | -7.1% | – |
| Gross Profit | $9,758,000 | $7,743,000 | $7,717,000 | $7,844,000 |
| % Margin | 74.1% | 72.1% | 72.8% | 68.7% |
| EBITDA | $4,214,000 | $1,889,000 | $2,770,000 | $563,000 |
| % Margin | 32% | 17.6% | 26.1% | 4.9% |
| Net Income | $2,802,000 | $3,940,000 | $1,872,000 | $683,000 |
| % Margin | 21.3% | 36.7% | 17.7% | 6% |
| EPS Diluted | 2.27 | 3.19 | 1.52 | 0.4 |
| % Growth | -28.8% | 109.9% | 280% | – |
| Operating Cash Flow | – | $0 | $2,093,000 | $0 |
| Capital Expenditures | – | $0 | $0 | $0 |
| Free Cash Flow | – | $0 | $2,093,000 | $0 |